Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TATA-box binding protein associated factor 10 (TAF10) is a small subunit of the TFIID complex, crucial for the initiation of transcription by RNA polymerase II[1][7]. TFIID, composed of TBP and TBP-associated factors (TAFs), facilitates promoter recognition, complex assembly, and transmission of regulatory signals. TAF10 also participates in co-activator complexes such as SAGA and influences specific gene regulation through post-translational modifications[2]. Functional TAF10 is required for normal development and gene expression. The ENSG00000248209 entry appears to refer to a pseudogene and does not encode a functional protein. In summary, ENSG00000248209 is not a valid target; the canonical target is TAF10 (TATA-box binding protein associated factor 10), ENSG00000166337. The pseudogene is not biologically active, nor a therapeutic target. All functional information applies to the bona fide TAF10 protein-coding gene, not the pseudogene[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TATA-box binding protein associated factor 10 (TAF10).